Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers tablets, hard capsules, granules, and pills. The company also produces and sells oral liquids, mixtures, wine, tinctures, decoctions, and syrups, as well as patent medicines; and provides pharmaceutical technology consulting services. Its products include drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu tablets, Hedan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, including Gushukang capsules/granules and Yuandu Hanbi liquid; Amber stone granules for urinary system diseases; Children's antipyretic granules for pediatric medication; Anti-itching granules for skin diseases; and Bile grass capsule for digestive and gynecological diseases, as well as Silkworm Nourishing Blood and Benefiting Kidney Granules for gynecological medication. In addition, the company offers Amber Xiaoshi granules, Siyu Yangxue Yishen granules, and Liuwei Dihuang pills for kidney-tonifying, menstruation-regulating, and nerve-soothing general medication; Yanreqing granules, Antiviral oral liquid, and Niuhuang Yijin tablets for the treatment of dry throat and sore throat; Xiaoer Tuire Granules, Fufang Xiling Jiedu Tablets, Yuandu Ganmao granules, and Yinhuang granules for the treatment of wind-heat colds; Tongxuan Lifei pills for the treatment of wind-cold colds; Fangfeng Tongsheng pills for colds on the surface and heat inside; Huoxiang Zhengqi Water for the treatment of summer-heat colds; Shenling Baizhu, Buzhong Yiqi, and Xiangsha Liujun pills for the treatment of physical weakness colds; and Juhong Li Gao for the treatment of dry coughs with little sputum. The company was founded in 2003 and is headquartered in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment Group Co., Ltd.
Metrics to compare | 002107 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002107PeersSector | |
---|---|---|---|---|
P/E Ratio | 58.4x | −14.8x | −0.5x | |
PEG Ratio | 0.61 | 0.01 | 0.00 | |
Price/Book | 5.5x | 3.3x | 2.6x | |
Price / LTM Sales | 5.1x | 4.8x | 3.3x | |
Upside (Analyst Target) | - | −9.3% | 43.3% | |
Fair Value Upside | Unlock | −9.8% | 6.9% | Unlock |